Active Biotech AB (publ) (STO:ACTI)

Active Biotech AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 4, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	127	116	165	255	276	274
Market Cap Growth	17.64%	-29.80%	-35.20%	-7.51%	0.37%	-16.00%
Enterprise Value	118	112	163	204	207	245
Last Close Price	0.05	0.09	0.16	0.31	0.39	0.58
PS Ratio	-	-	-	-	-	40.82
PB Ratio	28.24	3.54	5.39	7.38	5.90	12.41
P/TBV Ratio	29.55	3.57	5.43	7.44	5.90	12.41
EV/Sales Ratio	-	-	-	-	-	36.37
Debt / Equity Ratio	0.09	0.10	0.15	0.18	0.02	0.09
Net Debt / Equity Ratio	-1.93	-0.74	-1.03	-1.04	-1.12	-1.09
Net Debt / EBITDA Ratio	0.23	0.63	0.71	0.62	1.08	0.78
Net Debt / FCF Ratio	0.24	0.60	0.69	0.65	1.13	0.75
Asset Turnover	-	-	-	-	-	0.14
Quick Ratio	1.17	4.14	3.61	3.54	5.49	2.97
Current Ratio	1.17	4.40	3.73	3.66	5.64	3.24
Return on Equity (ROE)	-1305.02%	-124.26%	-140.54%	-143.80%	-144.87%	-84.97%
Return on Assets (ROA)	-152.20%	-57.09%	-61.13%	-67.12%	-69.95%	-40.74%
Return on Capital Employed (ROCE)	-792.70%	-116.20%	-138.10%	-148.60%	-106.10%	-141.70%
Earnings Yield	-30.30%	-33.98%	-27.73%	-22.91%	-18.08%	-11.75%
FCF Yield	-	-34.86%	-27.70%	-21.52%	-16.76%	-11.74%
Buyback Yield / Dilution	-211.51%	-54.84%	-16.21%	-9.23%	-26.87%	-16.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.